PBRM1 mutations have been shown to be prevalent in approximately 40% of ccRCC tumors [1, 3, 4] and loss of PBRM1 expression has been shown to be associated with overall survival [4]. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.